Ocular Therapeutix
Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.
相关临床试验
34
3 进行中
药物批准
2
批准总数
监管机构
1
监管机构数
成立时间
2006
进行中（未招募）
3
8.8%
已完成
24
70.6%
招募中
4
11.8%
终止
1
2.9%
Unknown
1
2.9%
撤回
1
2.9%
暂无资讯文章
